TRPV1 and hepatocellular carcinoma: However, due to the insufficient number of events in the co-high expression group of the combination F2-GOT2-TRPV1, there was marginally significant difference found in the overall survival rate of HCC patients between the co-high expression group and the co-low expression group of the protein combination F2-GOT2-TRPV1 (p = 0.051) (Figure 8B).